Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: A Multidisciplinary Discussion

June 9, 2020

Outcomes in the first 100 patients in the OPuS One Clinical Study were recently published in the JVIR November edition. View the publication –

A multidisciplinary panel presents a high-level overview of the OPuS One Post-Market Clinical Study evaluating the effectiveness of the OsteoCool™ Radiofrequency Ablation System, dives deeper into the latest data released on 100 patients treated, and discusses the benefits of taking a multidisciplinary approach to treating patients with metastatic bone disease. For more information on the OPuS One Study, please visit

Login to view comments. Click here to Login